American Capital Management Inc. Buys Shares of 104,967 Merit Medical Systems, Inc. $MMSI

Key Points

• American Capital Management acquired 104,967 Merit Medical shares worth approximately $7.28 million, representing about 0.18% of the company. Institutional investors collectively own 99.66% of MMSI.
• Analysts maintain a favorable outlook, with eight Buy ratings and four Holds producing a consensus “Moderate Buy” rating and an average price target of $100.
• Merit Medical exceeded quarterly expectations, reporting $1.19 in EPS versus the $0.96 consensus and $418.84 million in revenue, up 9.5% year over year. Shares traded near their 52-week high, though the valuation remains elevated at a P/E above 37.

American Capital Management Inc. acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 104,967 shares of the medical instruments supplier's stock, valued at approximately $7,278,000. American Capital Management Inc. owned about 0.18% of Merit Medical Systems at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of MMSI. AQR Capital Management LLC boosted its holdings in Merit Medical Systems by 7.3% in the 1st quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier's stock worth $1,730,000 after buying an additional 1,114 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Merit Medical Systems by 16.9% during the first quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier's stock worth $76,039,000 after acquiring an additional 103,878 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Merit Medical Systems by 745.9% in the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier's stock worth $86,000 after acquiring an additional 813 shares during the period. First Trust Advisors LP boosted its holdings in shares of Merit Medical Systems by 24.8% in the second quarter. First Trust Advisors LP now owns 59,215 shares of the medical instruments supplier's stock worth $5,535,000 after acquiring an additional 11,770 shares during the period. Finally, Cerity Partners LLC grew its position in shares of Merit Medical Systems by 9.1% in the second quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier's stock valued at $282,000 after purchasing an additional 251 shares in the last quarter. 99.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on MMSI shares. Piper Sandler increased their target price on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an "overweight" rating in a research note on Friday, July 31st. JPMorgan Chase & Co. boosted their price target on shares of Merit Medical Systems from $77.00 to $95.00 and gave the company an "overweight" rating in a research report on Friday, July 31st. BTIG Research reaffirmed a "buy" rating and issued a $105.00 price target on shares of Merit Medical Systems in a report on Tuesday, August 11th. Wells Fargo & Company increased their price objective on Merit Medical Systems from $74.00 to $83.00 and gave the stock an "equal weight" rating in a research report on Friday, July 31st. Finally, Weiss Ratings raised Merit Medical Systems from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, August 18th. Eight research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $100.00.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $90.54 on Thursday. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The company's 50-day moving average is $78.85 and its 200 day moving average is $72.74. The stock has a market capitalization of $5.41 billion, a P/E ratio of 37.41, a P/E/G ratio of 2.27 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.23. The company had revenue of $418.84 million during the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. Merit Medical Systems's quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the business earned $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, sell-side analysts expect that Merit Medical Systems, Inc. will post 3.84 earnings per share for the current year.

Key Headlines Impacting Merit Medical Systems

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Zacks Research raised several earnings forecasts. The firm increased its FY2026 EPS estimate to $3.73 from $3.57, FY2027 to $4.01 from $3.82, and FY2028 to $4.32 from $4.12. It also lifted estimates for Q2 2027, Q3 2027, Q1 2028, and Q2 2028. The revisions suggest improved confidence in Merit Medical’s longer-term earnings growth.
• Positive Sentiment: Longer-term earnings expectations are moving higher. The revised FY2027 and FY2028 forecasts exceed the current-year consensus estimate of roughly $3.81–$3.84 per share, reinforcing the outlook for continued earnings expansion.
• Neutral Sentiment: Short-interest data appears unusable. The report lists short interest at zero shares and describes the change as “NaN,” with a zero days-to-cover ratio. This does not provide a meaningful signal about short-selling pressure or potential short covering.
• Negative Sentiment: One near-term estimate was reduced. Zacks lowered its Q4 2026 EPS forecast slightly to $0.98 from $0.99. While the change is minor, it offsets some of the broader positive revisions and indicates limited near-term earnings impact.
• Negative Sentiment: Valuation leaves less room for disappointment. Merit Medical’s shares recently traded near their 52-week high, with a P/E ratio above 37 and a PEG ratio above 2. Stronger earnings expectations are supportive, but the premium valuation could weigh on the stock if results or guidance fall short.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source